European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017 - MarketsandMarkets

European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017

European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017 - MarketsandMarkets
European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017
Published Jun 24, 2013
300 pages — Published Jun 24, 2013
Price US$ 4,650.00  |  Buy this Report Now

About This Report

  
Abstract:



The European drug delivery technology market was worth $39.9 billion in the year 2012. The market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery. Over the years, European drug delivery technology have grown phenomenally from plain drug reformulation and release technologies, to innovative platforms that hold a huge potential for the effective delivery of biologicals and novel drugs.

Patent expiries of certain blockbuster drugs, growing demand for self-administration and home healthcare devices, rising incidence of chronic diseases such as cardiovascular diseases, diabetes and cancer and growing focus on pediatric and geriatric patients are accelerating the growth of this market. However, drug failures and recalls and technical barriers are estimated to hamper the growth of this market. Over the years, European drug delivery technology have grown phenomenally from plain drug reformulation and release technologies to innovative platforms that hold a huge potential for the effective delivery of biologicals and novel drugs.

The growing number of elderly persons is a large consumer of home care drug delivery devices. Expanding applications of drug delivery into niche therapeutic areas, strategic collaborations and self-administration and home care drug delivery devices represent vast opportunities for key players in this market. According to a 2012 report published by the World Economic Forum (WEF), the total geriatric population of Switzerland (aged 60 years and older) was 23% of the total population. This number is expected to increase to 32% by 2030 and to 37% by 2050. An increase in the number of geriatric patients and rise in demand for convenient drug delivery options pose major opportunities for the development of innovative and easy-to-use systems.

The geographies covered in this study are Germany, France, United Kingdom, Spain, Italy, Russia and Rest of Europe (RoE). Germany is the largest market for drug delivery, followed by France and the U.K. However, these countries are expected to grow at a slower pace than Russia and RoE, primarily due to a certain amount of saturation in the market. The latter markets are poised to register maximum growth over the next five years, owing to the expansion of these economies, increase in disposable income, development of healthcare infrastructure, increasing penetration of health insurance, and rising prevalence of chronic diseases.

Scope of the Report

This research report categorizes the European drug delivery technology market into oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the markets is comprehensively analyzed at a granular level by geography (Germany, France, United Kingdom, Spain, Italy, Russia and Rest of Europe) to provide in-depth information on the European scenario of this market.

European drug delivery market, by technologies

Oral
Controlled Release
Orodispersible Tablets (ODT) and Taste Masking
Others
Pulmonary
Dry Powder Inhalers
Metered Dose Inhalers
Nebulizers
Transdermal
Passive
Reservoir System
Matrix System
Active
Iontophoresis
Microporation
Others
Injectable
Conventional Injection Devices
Fillable Syringes
Prefilled Syringes
Self-injection Devices
Needle-free Injecto

  
Source:
Document ID
BT 2060
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

Title
Table Of Contents

1 Introduction (Page No. - 22)
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
1.5.5 Assumptions

2 Executive Summary (Page No. - 29)

3 Market Overview (Page No. - 34)
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Patent Cliff And Increased Competition To Increase Adoption Rate
3.2.1.2 Improving Patient Compliance And Acceptability, An Impetus To The Drug Delivery Systems Market
3.2.1.3 Increasing Focus On Pediatric And Geriatric Patients To Boost Overall Growth
3.2.1.4 Increasing Incidence Of Chronic Diseases Like Cancer And Diabetes To Enhance Demand For Drug Delivery Technologies
3.2.1.5 Higher Premature Mortality Rates In Eastern Europe And Russia Suggests Need For Better Medication
3.2.2 Restraints
3.2.2.1 Drug Failures And Recalls Mar Market Growth
3.2.2.2 Technical Barriers Restrict Growth
3.2.3 Opportunities
3.2.3.1 Collaborations Between Pharmaceutical Companies And Drug Delivery Firms
3.2.3.2 Self-Administration And Home Care Drug Delivery Devices
3.2.3.3 Expanding Therapeutic Applications Of Drug Delivery Technologies
3.2.4 Targeted Drug Delivery
3.2.4.1 Passive Systems Contribute 60% To The Targeted Drug Delivery Market
3.2.4.2 Active Targeted Drug Delivery Has Major Applications In Cancer Therapy
3.2.4.3 Companies Focus On Novel Targeted Drug Delivery
3.2.5 Burning Issues
3.2.5.1 Striking Right Partnerships
3.2.5.2 Improving The Bioavailability Of Drugs
3.3 Regulatory Affairs
3.3.1 European Union Regulatory Framework
3.3.2 Germany
3.3.2.1 Bundesministerium Für Gesundheit (Ministry Of Health)
3.3.2.2 Bundesinstitut Für Arzneimittel Und Medizinprodukte (Federal Institute For Drugs And Medical Devices)
3.3.3 U.K.
3.3.3.1 The Medicines And Healthcare Products Regulatory Agency (MHRA)
3.3.4 France
3.3.4.1 Agence Nationale De Sécurité Du Médicament Et Des Produits De Santé (National Agency For The Safety Of Medicines And Health Products)
3.3.5 Spain
3.3.5.1 Agencia Espagnola De Medicamentos Y Productos Sanitarios (Spanish Medicines And Health Products Agency)
3.3.6 Italy
3.3.6.1 Agenzia Italiana Del Farmaco (Italian Medicines Agency)
3.3.7 Russia
3.3.7.1 Association Of International Pharmaceutical Manufacturers (AIPM)
3.4 Reimbursement Scenario In The European Union
3.5 Market Segmentation
3.6 Porter's Five Forces Analysis
3.7 Value Chain Analysis
3.8 Market Share Analysis
3.8.1 Pulmonary Drug Delivery
3.8.2 Injectable Drug Delivery
3.8.2.1 Conventional Injection Devices
3.8.2.2 Self-Injection Devices

4 Global Drug Delivery Market, By Technology (Page No. - 64)
4.1 Introduction
4.2 Opportunity Matrix
4.3 Oral Drug Delivery
4.3.1 Controlled Release
4.3.2 Orodispersible Tablets (ODT) And Taste Masking
4.3.3 Others
4.4 Pulmonary Drug Delivery
4.4.1 Therapeutic Applications Of Pulmonary Delivery
4.4.2 Metered Dose Inhalers (MDI)
4.4.3 Dry Powder Inhalers (DPI)
4.4.4 Nebulizers

Table Of Contents

MarketsandMarkets—Worldwide, market research reports primarily sold for numbers, market segmentation and competitive landscape, within the business leaders.

About the Author


Cite this Report

  
MLA:
MarketsandMarkets. "European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017" Jun 24, 2013. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/MarketsandMarkets/European-Drug-Delivery-Technologies-Market-Metered-Dose-Inhalers-Needle-Free-injectors-Auto-injectors-Nasal-sprays-Transdermal-Patches-Nebulizers-Infusion-Pumps-Drug-Eluting-Stents-Sustained-Release-Ocular-Implants-Forecasts-to-2017-2144-162>
  
APA:
MarketsandMarkets. (2013). European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017 Jun 24, 2013. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/MarketsandMarkets/European-Drug-Delivery-Technologies-Market-Metered-Dose-Inhalers-Needle-Free-injectors-Auto-injectors-Nasal-sprays-Transdermal-Patches-Nebulizers-Infusion-Pumps-Drug-Eluting-Stents-Sustained-Release-Ocular-Implants-Forecasts-to-2017-2144-162>
  
US$ 4,650.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.